Abstract
We attempted to produce a monoclonal antibody (MAb) against the active site of native thrombin. Bovine thrombin was treated with diisopropyl fluorophosphate, and prepared diisopropylphosphoryl-thrombin was used for the immunization to BALB/c mice. Spleen cells of immunized mice were hybridized with mouse myeloma cells P3U1, and a hybridoma clone CC2, which produced a MAb against bovine thrombin was established. The MAb produced by hybridoma clone CC2 (MAbCC2), consisting of IgG1 and κ light chain, was purified using protein A affinity chromatography. Purified MAbCC2 prolonged the fibrin forming time of bovine thrombin and inhibited the release of fibrinopeptide A from rabbit fibrinogen. In addition, it was found that argatroban partially, but competitively, interfere the binding between MAbCC2 and bovine thrombin. It was then considered that MAbCC2 would bind to the molecular structure associating primary specific pocket in the active site of bovine thrombin.
Get full access to this article
View all access options for this article.
